Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp rat

The corpulent JCR:LA-cp rat (cp/cp) is a useful model for study of the metabolic consequences of obesity and hyperinsulinemia. To assess the effect of hyperinsulinemia on VLDL secretion in this model, we measured rates of secretion of VLDL in perfused livers derived from cp/cp rats and their lean li...

Full description

Bibliographic Details
Main Authors: Marshall B. Elam, Henry G. Wilcox, Lauren M. Cagen, Xiong Deng, Rajendra Raghow, Poonam Kumar, Murray Heimberg, James C. Russell
Format: Article
Language:English
Published: Elsevier 2001-12-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520315339
_version_ 1818384694882861056
author Marshall B. Elam
Henry G. Wilcox
Lauren M. Cagen
Xiong Deng
Rajendra Raghow
Poonam Kumar
Murray Heimberg
James C. Russell
author_facet Marshall B. Elam
Henry G. Wilcox
Lauren M. Cagen
Xiong Deng
Rajendra Raghow
Poonam Kumar
Murray Heimberg
James C. Russell
author_sort Marshall B. Elam
collection DOAJ
description The corpulent JCR:LA-cp rat (cp/cp) is a useful model for study of the metabolic consequences of obesity and hyperinsulinemia. To assess the effect of hyperinsulinemia on VLDL secretion in this model, we measured rates of secretion of VLDL in perfused livers derived from cp/cp rats and their lean littermates. Livers of cp/cp rats secreted significantly greater amounts of VLDL triglyceride and apolipoprotein, compared with lean littermates. The content of apoB, apoE, and apoCs in both perfusate and plasma VLDL was greater in the cp/cp rat, as was the apolipoprotein (apo)C, apoA-I, and apoA-IV content of plasma HDL. Triglyceride content was also greater in cp/cp livers, as was hepatic lipogenesis and expression of lipogenic enzymes and sterol regulatory element binding protein-1 (SREBP-1). Hepatic mRNAs for apoE, and apoA-I were higher in livers of cp/cp rats. In contrast, the steady state levels of apoC-II, apoC-III, and apoB mRNAs were unchanged. Thus, livers of obese hyperinsulinemic cp/cp JCR:LA-cp rats secrete a greater number of VLDL particles that are enriched in triglyceride, apoE, and apoC. Greater secretion of VLDL in the cp/cp rat in part results from higher endogenous fatty acid synthesis, which in turn may occur in response to increased expression of the lipogenic enzyme regulator SREBP-1c.—Elam, M. B., H. G. Wilcox, L. M. Cagen, X. Deng, R. Raghow, P. Kumar, M. Heimberg, and J. C. Russell. Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp rat. J. Lipid Res. 2001. 42: 2039–2048.
first_indexed 2024-12-14T03:26:20Z
format Article
id doaj.art-b965049c35d04370b533667cfb56f062
institution Directory Open Access Journal
issn 0022-2275
language English
last_indexed 2024-12-14T03:26:20Z
publishDate 2001-12-01
publisher Elsevier
record_format Article
series Journal of Lipid Research
spelling doaj.art-b965049c35d04370b533667cfb56f0622022-12-21T23:18:53ZengElsevierJournal of Lipid Research0022-22752001-12-01421220392048Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp ratMarshall B. Elam0Henry G. Wilcox1Lauren M. Cagen2Xiong Deng3Rajendra Raghow4Poonam Kumar5Murray Heimberg6James C. Russell7To whom correspondence should be addressed at Division of Clinical Pharmacology, University of Tennessee Health Sciences Center, 874 Union Avenue, Memphis, TN, 38112.; Department of Veterans Affairs Medical Center, University of Tennessee Health Sciences Center, Memphis, TN; Divisions of Clinical Pharmacology and Cardiovascular Diseases, University of Tennessee Health Sciences Center, Memphis, TNDepartments of Pharmacology and Medicine, University of Tennessee Health Sciences Center, Memphis, TNDepartments of Pharmacology and Medicine, University of Tennessee Health Sciences Center, Memphis, TNDepartments of Pharmacology and Medicine, University of Tennessee Health Sciences Center, Memphis, TNDepartment of Veterans Affairs Medical Center, University of Tennessee Health Sciences Center, Memphis, TN; Departments of Pharmacology and Medicine, University of Tennessee Health Sciences Center, Memphis, TNDepartments of Pharmacology and Medicine, University of Tennessee Health Sciences Center, Memphis, TNDepartment of Veterans Affairs Medical Center, University of Tennessee Health Sciences Center, Memphis, TN; Departments of Pharmacology and Medicine, University of Tennessee Health Sciences Center, Memphis, TNDepartment of Surgery, University of Alberta, Edmonton, CanadaThe corpulent JCR:LA-cp rat (cp/cp) is a useful model for study of the metabolic consequences of obesity and hyperinsulinemia. To assess the effect of hyperinsulinemia on VLDL secretion in this model, we measured rates of secretion of VLDL in perfused livers derived from cp/cp rats and their lean littermates. Livers of cp/cp rats secreted significantly greater amounts of VLDL triglyceride and apolipoprotein, compared with lean littermates. The content of apoB, apoE, and apoCs in both perfusate and plasma VLDL was greater in the cp/cp rat, as was the apolipoprotein (apo)C, apoA-I, and apoA-IV content of plasma HDL. Triglyceride content was also greater in cp/cp livers, as was hepatic lipogenesis and expression of lipogenic enzymes and sterol regulatory element binding protein-1 (SREBP-1). Hepatic mRNAs for apoE, and apoA-I were higher in livers of cp/cp rats. In contrast, the steady state levels of apoC-II, apoC-III, and apoB mRNAs were unchanged. Thus, livers of obese hyperinsulinemic cp/cp JCR:LA-cp rats secrete a greater number of VLDL particles that are enriched in triglyceride, apoE, and apoC. Greater secretion of VLDL in the cp/cp rat in part results from higher endogenous fatty acid synthesis, which in turn may occur in response to increased expression of the lipogenic enzyme regulator SREBP-1c.—Elam, M. B., H. G. Wilcox, L. M. Cagen, X. Deng, R. Raghow, P. Kumar, M. Heimberg, and J. C. Russell. Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp rat. J. Lipid Res. 2001. 42: 2039–2048.http://www.sciencedirect.com/science/article/pii/S0022227520315339animalcells culturedliverobesityinsulinapolipoprotein
spellingShingle Marshall B. Elam
Henry G. Wilcox
Lauren M. Cagen
Xiong Deng
Rajendra Raghow
Poonam Kumar
Murray Heimberg
James C. Russell
Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp rat
Journal of Lipid Research
animal
cells cultured
liver
obesity
insulin
apolipoprotein
title Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp rat
title_full Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp rat
title_fullStr Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp rat
title_full_unstemmed Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp rat
title_short Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp rat
title_sort increased hepatic vldl secretion lipogenesis and srebp 1 expression in the corpulent jcr la cp rat
topic animal
cells cultured
liver
obesity
insulin
apolipoprotein
url http://www.sciencedirect.com/science/article/pii/S0022227520315339
work_keys_str_mv AT marshallbelam increasedhepaticvldlsecretionlipogenesisandsrebp1expressioninthecorpulentjcrlacprat
AT henrygwilcox increasedhepaticvldlsecretionlipogenesisandsrebp1expressioninthecorpulentjcrlacprat
AT laurenmcagen increasedhepaticvldlsecretionlipogenesisandsrebp1expressioninthecorpulentjcrlacprat
AT xiongdeng increasedhepaticvldlsecretionlipogenesisandsrebp1expressioninthecorpulentjcrlacprat
AT rajendraraghow increasedhepaticvldlsecretionlipogenesisandsrebp1expressioninthecorpulentjcrlacprat
AT poonamkumar increasedhepaticvldlsecretionlipogenesisandsrebp1expressioninthecorpulentjcrlacprat
AT murrayheimberg increasedhepaticvldlsecretionlipogenesisandsrebp1expressioninthecorpulentjcrlacprat
AT jamescrussell increasedhepaticvldlsecretionlipogenesisandsrebp1expressioninthecorpulentjcrlacprat